PET Imaging in Bladder Cancer: An Update and Future Direction

Molecular imaging with positron emission tomography is a powerful tool in bladder cancer management. In this review, we aim to address the current place of the PET imaging in bladder cancer care and offer perspectives on potential future radiopharmaceutical and technological advancements. A special...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang-Yin, Jules, Girard, Antoine, Marchal, Etienne, Lebret, Thierry, Homo Seban, Marie, Uhl, Marine, Bertaux, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144644/
https://www.ncbi.nlm.nih.gov/pubmed/37111363
http://dx.doi.org/10.3390/ph16040606
_version_ 1785034147541024768
author Zhang-Yin, Jules
Girard, Antoine
Marchal, Etienne
Lebret, Thierry
Homo Seban, Marie
Uhl, Marine
Bertaux, Marc
author_facet Zhang-Yin, Jules
Girard, Antoine
Marchal, Etienne
Lebret, Thierry
Homo Seban, Marie
Uhl, Marine
Bertaux, Marc
author_sort Zhang-Yin, Jules
collection PubMed
description Molecular imaging with positron emission tomography is a powerful tool in bladder cancer management. In this review, we aim to address the current place of the PET imaging in bladder cancer care and offer perspectives on potential future radiopharmaceutical and technological advancements. A special focus is given to the following: the role of [(18)F] 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in the clinical management of bladder cancer patients, especially for staging and follow-up; treatment guided by [(18)F]FDG PET/CT; the role of [(18)F]FDG PET/MRI, the other PET radiopharmaceuticals beyond [(18)F]FDG, such as [(68)Ga]- or [(18)F]-labeled fibroblast activation protein inhibitor; and the application of artificial intelligence.
format Online
Article
Text
id pubmed-10144644
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101446442023-04-29 PET Imaging in Bladder Cancer: An Update and Future Direction Zhang-Yin, Jules Girard, Antoine Marchal, Etienne Lebret, Thierry Homo Seban, Marie Uhl, Marine Bertaux, Marc Pharmaceuticals (Basel) Review Molecular imaging with positron emission tomography is a powerful tool in bladder cancer management. In this review, we aim to address the current place of the PET imaging in bladder cancer care and offer perspectives on potential future radiopharmaceutical and technological advancements. A special focus is given to the following: the role of [(18)F] 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in the clinical management of bladder cancer patients, especially for staging and follow-up; treatment guided by [(18)F]FDG PET/CT; the role of [(18)F]FDG PET/MRI, the other PET radiopharmaceuticals beyond [(18)F]FDG, such as [(68)Ga]- or [(18)F]-labeled fibroblast activation protein inhibitor; and the application of artificial intelligence. MDPI 2023-04-17 /pmc/articles/PMC10144644/ /pubmed/37111363 http://dx.doi.org/10.3390/ph16040606 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zhang-Yin, Jules
Girard, Antoine
Marchal, Etienne
Lebret, Thierry
Homo Seban, Marie
Uhl, Marine
Bertaux, Marc
PET Imaging in Bladder Cancer: An Update and Future Direction
title PET Imaging in Bladder Cancer: An Update and Future Direction
title_full PET Imaging in Bladder Cancer: An Update and Future Direction
title_fullStr PET Imaging in Bladder Cancer: An Update and Future Direction
title_full_unstemmed PET Imaging in Bladder Cancer: An Update and Future Direction
title_short PET Imaging in Bladder Cancer: An Update and Future Direction
title_sort pet imaging in bladder cancer: an update and future direction
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144644/
https://www.ncbi.nlm.nih.gov/pubmed/37111363
http://dx.doi.org/10.3390/ph16040606
work_keys_str_mv AT zhangyinjules petimaginginbladdercanceranupdateandfuturedirection
AT girardantoine petimaginginbladdercanceranupdateandfuturedirection
AT marchaletienne petimaginginbladdercanceranupdateandfuturedirection
AT lebretthierry petimaginginbladdercanceranupdateandfuturedirection
AT homosebanmarie petimaginginbladdercanceranupdateandfuturedirection
AT uhlmarine petimaginginbladdercanceranupdateandfuturedirection
AT bertauxmarc petimaginginbladdercanceranupdateandfuturedirection

Ejemplares similares